Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

ClinicalTrials.gov ID: NCT02438007

Public ClinicalTrials.gov record NCT02438007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 15, 2026, 1:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ARMOR3-SV: A Phase 3, Randomized, Open Label, Multi-Center, Controlled Study of Galeterone Compared to Enzalutamide in Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic (M1) Castrate Resistant Prostate Cancer (CRPC)

Study identification

NCT ID
NCT02438007
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
LTN PHARMACEUTICALS, INC.
Industry
Enrollment
953 participants

Conditions and interventions

Interventions

  • Enzalutamide Drug
  • Galeterone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Jun 30, 2016
Completion
Oct 31, 2016
Last update posted
Mar 14, 2023

2015 – 2016

United States locations

U.S. sites
51
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
Pinnacle Oncology Hematology Scottsdale Arizona 85258
University Of Arizona Cancer Center Tucson Arizona 85724
City of Hope Duarte California 91010
USC Norris Comprehensive Cancer Center Los Angeles California 90033
UCLA Jonsson Comprehensive Cancer Center Los Angeles California 90095
Prostate Oncology Specialists, Inc. Marina del Rey California 90292
UC Davis Cancer Center Sacramento California 95817
San Bernardino Urological Associates San Bernardino California 92404
Urology Speciality Group Torrance California 90505
University of Colorado Cancer Center Anschultz Cancer Pavilion Aurora Colorado 80045
The Urology Center of Colorado Denver Colorado 80211
Yale University School of Medicine New Haven Connecticut 06510
Georgetown University Medical Center Washington D.C. District of Columbia 20007
Sibley Memorial Hospital Washington D.C. District of Columbia 20016
Boca Raton Community Hospital, Inc. Boca Raton Florida 33486
University of Florida Health Cancer Center Orlando Florida 32806
Moffitt Cancer Center Tampa Florida 33612
First Urology Jeffersonville Indiana 47130
Tulane Medical Center New Orleans Louisiana 70115
Regional Urology, LLC Shreveport Louisiana 71106
University of Maryland Greenenbaum Cancer Center Baltimore Maryland 21201
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21205
Walter Reed National Military Medical Center Bethesda Maryland 20307
Massachusetts General Hospital Boston Massachusetts 02114
Dana-Farber Cancer Institute Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Health System Ann Arbor Michigan 48109
Karmanos Cancer Center Detroit Michigan 48201
Urology Cancer Center and GU Research Network Omaha Nebraska 68130
Coastal Urology Associates Brick New Jersey 08724
Brooklyn Urology Research Group Brooklyn New York 11215
Advanced Urology Centers of New York Plainview New York 11803
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601
Associated Medical Professionals of NY Syracuse New York 13210
University of North Carolina Lineberger Cancer Center Chapel Hill North Carolina 27599
Carolina Urology Partners, PLLC Charlotte North Carolina 28277
Carolina Urology Partners Concord North Carolina 28025
The Urology Group Cincinnati Ohio 45212
Clinical Research Solutions Middleburg Heights Ohio 44130
Oregon Urology Institute Springfield Oregon 97477
Lancaster Urology Lancaster Pennsylvania 17604
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
UPMC Cancer Centers Pittsburgh Pennsylvania 15232
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Urology Associates Clinical Research Nashville Tennessee 37209
Urology Clinics of North Texas Dallas Texas 75231
Texas Oncology/Baylor University Medical Center Dallas Texas 75246
Urology San Antonio San Antonio Texas 78229
Virginia Urology Richmond Virginia 23235
Urology of Virginia Virginia Beach Virginia 23462
The University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02438007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2023 · Synced May 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02438007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →